Rang	Name	Position
1	Mr. Daniel Barber	CEO, President & Director
2	Mr. A. Ernest Toth Jr.	Senior VP & CFO
3	Ms. Lori J. Braender BSBA, Esq., J.D.	Corporate Secretary
4	Ms. Cassie Jung	Chief Operating Officer
5	Mr. Thomas A. Zalewski	Chief Legal Officer & Chief Compliance Officer
6	Mr. Peter E. Boyd	Senior Vice President of Information Technology & Chief People Officer
7	Dr. Matthew Greenhawt B.Sc., M.B.A., M.D.	Chief Medical Officer
8	Ms. Sherry Korczynski	Chief Commercial Officer
9	Dr. Melina T. Cioffi Pharm.D.	Senior Vice President of Regulatory Affairs
10	Dr. Matthew William Davis M.D., R.Ph.	Chief Development Officer

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Bratton Capital Management, L.P.	7,82%	46,90 Mio. USD
2	BlackRock Inc	5,98%	35,89 Mio. USD
3	RTW INVESTMENTS, LLC	5,92%	35,50 Mio. USD
4	Vanguard Capital Management, LLC	3,54%	21,24 Mio. USD
5	Federated Hermes Inc	2,48%	14,88 Mio. USD
6	Balyasny Asset Management LLC	2,31%	13,87 Mio. USD
7	State Street Corp	2,03%	12,17 Mio. USD
8	Samsara BioCapital, LLC	1,99%	11,95 Mio. USD
9	Geode Capital Management, LLC	1,92%	11,51 Mio. USD
10	Bank of America Corp	1,92%	11,50 Mio. USD
11	Morgan Stanley - Brokerage Accounts	1,27%	7,61 Mio. USD
12	Sio Capital Management, LLC	1,18%	7,10 Mio. USD
13	Propel Bio Management LLC	1,15%	6,90 Mio. USD
14	Wasatch Advisors LP	1,10%	6,63 Mio. USD
15	Two Sigma Investments LLC	1,02%	6,12 Mio. USD
16	Janney Montgomery Scott LLC	0,87%	5,21 Mio. USD
17	Commonwealth Equity Services, LLC	0,83%	5,00 Mio. USD
18	Wells Fargo & Co	0,82%	4,95 Mio. USD
19	Jane Street Group LLC	0,82%	4,92 Mio. USD
20	Blue Owl Capital Holdings LP	0,75%	4,51 Mio. USD